Cargando…

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis

Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular diseases. The progression of AS is a multi-step process leading to high morbidity and mortality. Hyperglycemia, dyslipidemia, advanced glycation end products (AGEs), inflammation and insulin resistance which s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Lin, Yin, Ruili, Yang, Longyan, Zhao, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470882/ https://www.ncbi.nlm.nih.gov/pubmed/36120471 http://dx.doi.org/10.3389/fendo.2022.983723

Ejemplares similares

Exosomes Derived From Mesenchymal Stromal Cells Pretreated With Advanced Glycation End Product-Bovine Serum Albumin Inhibit Calcification of Vascular Smooth Muscle Cells
por: Wang, Ying, et al.
Publicado: (2018)

Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification
por: Koike, Sayo, et al.
Publicado: (2016)

Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes
por: Al-Saoudi, Elaf, et al.
Publicado: (2022)

Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease
por: Zhang, Xue-Meng, et al.
Publicado: (2022)

Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function
por: Simard, Elie, et al.
Publicado: (2015)

The role of autophagy in advanced glycation end product-induced proliferation and migration in rat vascular smooth muscle cells
por: Liu, Zhigang, et al.
Publicado: (2018)

The role of advanced glycation end products in fracture risk assessment in postmenopausal type 2 diabetic patients
por: Gao, Liu, et al.
Publicado: (2022)

Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products
por: Dai, Yimin, et al.
Publicado: (2023)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018)

ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells
por: HU, PENGFEI, et al.
Publicado: (2012)

Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes
por: Phimphilai, Mattabhorn, et al.
Publicado: (2021)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated-M1 Macrophage Polarization-Dependent Vascular Smooth Muscle Cell Phenotypic Conversion
por: Xing, Yujie, et al.
Publicado: (2022)

Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3
por: Li, Cunshu, et al.
Publicado: (2017)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Vascular Effects of Dietary Advanced Glycation End Products
por: Stirban, Alin, et al.
Publicado: (2015)

Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes
por: Phimphilai, Mattabhorn, et al.
Publicado: (2022)

Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity
por: Turki Jalil, Abduladheem, et al.
Publicado: (2022)

Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011)

Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2012)

Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State
por: Bao, Zhengyang, et al.
Publicado: (2020)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts
por: Kulkarni, Sudhir A., et al.
Publicado: (2022)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
por: Martin-Aragon Baudel, Miguel, et al.
Publicado: (2020)

Vascular Smooth Muscle Cells Contribute to Atherosclerosis Immunity
por: Hu, Desheng, et al.
Publicado: (2019)

Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling
por: Gao, Hongli, et al.
Publicado: (2017)

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
por: Lee, Jeongmin, et al.
Publicado: (2022)

Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: A Health Risk Factor Analysis Using the Body Mass Index as a Moderator
por: Zhang, Yi, et al.
Publicado: (2022)

Senescence in Vascular Smooth Muscle Cells and Atherosclerosis
por: Zha, Yiwen, et al.
Publicado: (2022)

S100A8 inhibits PDGF-induced proliferation of airway smooth muscle cells dependent on the receptor for advanced glycation end-products
por: Xu, Yu-Dong, et al.
Publicado: (2017)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
por: Saremi, Aramesh, et al.
Publicado: (2017)

Advanced Glycation End Products, Diabetes, and Bone Strength
por: Yamamoto, Masahiro, et al.
Publicado: (2016)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
por: Oshitari, Toshiyuki
Publicado: (2023)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Plasma Advanced Glycation End Products and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
por: BERGE, KRISTIAN, et al.
Publicado: (2023)

Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products
por: Zhang, Weijin, et al.
Publicado: (2015)

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
por: Ninomiya, Hiroyo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r0gd2o23te8q7273g8kn7jqhv5